Resolution Pharmacology: State-of-the-art and therapeutic landscape.

Area of Science:

• Pharmacology
• Inflammation Biology
• Drug Discovery

Background:

• The inflammatory response involves both pro-inflammatory and pro-resolving mediators acting in concert.
• Inflammation resolution is a robust physiological process, not merely a distinct phase after inflammation onset.
• Chronic non-resolving inflammation presents a challenge for current therapeutics.

Purpose of the Study:

• To update concepts of Resolution Pharmacology, emphasizing harnessing inflammation resolution for novel therapies.
• To explore the potential of targeting endogenous tissue-protective and regenerative pathways.
• To highlight Resolution Pharmacology as an untapped opportunity for pharmaceutical development.

Main Methods:

• Review and synthesis of recent developments in inflammation resolution biology.
• Analysis of the interplay between inflammatory and proresolving mediators.
• Conceptual framework for applying Resolution Pharmacology to therapeutic strategies.

Main Results:

• Resolution Pharmacology aims to leverage the body's natural resolution mechanisms.
• Proresolving drugs may be more effective in the presence of active inflammation.
• Therapeutics developed through Resolution Pharmacology could be disease-independent.

Conclusions:

• Harnessing inflammation resolution offers a promising avenue for developing innovative, patient-centric medicines.
• Targeting proresolving pathways promotes natural healing and repair processes.
• Resolution Pharmacology represents a significant, yet underdeveloped, area for pharmaceutical research and development.